Johnson & Johnson Total Assets 2006-2020 | JNJ
Johnson & Johnson total assets from 2006 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Johnson & Johnson total assets for the quarter ending June 30, 2020 were $158.380B, a 2.1% increase year-over-year.
- Johnson & Johnson total assets for 2019 were $157.728B, a 3.12% increase from 2018.
- Johnson & Johnson total assets for 2018 were $152.954B, a 2.76% decline from 2017.
- Johnson & Johnson total assets for 2017 were $157.303B, a 11.4% increase from 2016.
Johnson & Johnson Annual Total Assets
(Millions of US $) |
| 2019 |
$157,728 |
| 2018 |
$152,954 |
| 2017 |
$157,303 |
| 2016 |
$141,208 |
| 2015 |
$133,411 |
| 2014 |
$130,358 |
| 2013 |
$132,683 |
| 2012 |
$121,347 |
| 2011 |
$113,644 |
| 2010 |
$102,908 |
| 2009 |
$94,682 |
| 2008 |
$84,912 |
| 2007 |
$80,954 |
| 2006 |
$70,556 |
| 2005 |
$58,864 |
Johnson & Johnson Quarterly Total Assets
(Millions of US $) |
| 2020-06-30 |
$158,380 |
| 2020-03-31 |
$155,017 |
| 2019-12-31 |
$157,728 |
| 2019-09-30 |
$155,521 |
| 2019-06-30 |
$155,117 |
| 2019-03-31 |
$150,027 |
| 2018-12-31 |
$152,954 |
| 2018-09-30 |
$155,703 |
| 2018-06-30 |
$155,365 |
| 2018-03-31 |
$156,625 |
| 2017-12-31 |
$157,303 |
| 2017-09-30 |
$155,658 |
| 2017-06-30 |
$152,807 |
| 2017-03-31 |
$144,918 |
| 2016-12-31 |
$141,208 |
| 2016-09-30 |
$140,369 |
| 2016-06-30 |
$139,814 |
| 2016-03-31 |
$136,231 |
| 2015-12-31 |
$133,411 |
| 2015-09-30 |
$133,266 |
| 2015-06-30 |
$132,036 |
| 2015-03-31 |
$128,590 |
| 2014-12-31 |
$130,358 |
| 2014-09-30 |
$132,097 |
| 2014-06-30 |
$135,200 |
| 2014-03-31 |
$133,330 |
| 2013-12-31 |
$132,683 |
| 2013-09-30 |
$126,933 |
| 2013-06-30 |
$124,325 |
| 2013-03-31 |
$121,536 |
| 2012-12-31 |
$121,347 |
| 2012-09-30 |
$118,951 |
| 2012-06-30 |
$115,750 |
| 2012-03-31 |
$116,194 |
| 2011-12-31 |
$113,644 |
| 2011-09-30 |
$111,821 |
| 2011-06-30 |
$112,114 |
| 2011-03-31 |
$108,150 |
| 2010-12-31 |
$102,908 |
| 2010-09-30 |
$98,247 |
| 2010-06-30 |
$92,300 |
| 2010-03-31 |
$93,441 |
| 2009-12-31 |
$94,682 |
| 2009-09-30 |
$91,558 |
| 2009-06-30 |
$87,438 |
| 2009-03-31 |
$86,100 |
| 2008-12-31 |
$84,912 |
| 2008-09-30 |
$87,724 |
| 2008-06-30 |
$88,113 |
| 2008-03-31 |
$85,995 |
| 2007-12-31 |
$80,954 |
| 2007-09-30 |
$78,665 |
| 2007-06-30 |
$74,683 |
| 2007-03-31 |
$73,066 |
| 2006-12-31 |
$70,556 |
| 2006-09-30 |
$61,238 |
| 2006-06-30 |
$60,990 |
| 2006-03-31 |
$62,133 |
| 2005-12-31 |
$58,864 |
| 2005-09-30 |
$56,574 |
| 2005-06-30 |
$54,553 |
| 2005-03-31 |
$54,446 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$391.238B |
$82.059B |
|
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
|
